Thromboembolism: Clinical Trials

7 trials for Thromboembolism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown. 7 Phase 2, 4 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Unknown 7
Phase 34Unknown 4
Phase 11Unknown 1

Follow Thromboembolism: new trials by email Literature Review of Thromboembolism trials Research Report on Thromboembolism

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial
Anti-Xa Guided Dosing of Low Molecular Weight Heparin, Standard of Care Dosing - Venous Thromboembolism (VTE), Trauma Related Injuries
Phase 2 / Phase 3UnknownAlexandre Tran1502025-01-012024-10-28
A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement
Dimolegin 40 mg, Dimolegin 60 mg, Fragmin - Venous Thromboembolism
Phase 2UnknownPharmaDiall Ltd.2402019-05-312022-05-02
Efficacy Comparison of Warfarin Versus Rivaroxaban CVT
Rivaroxaban, Warfarin - Cerebral Venous Thrombosis
Phase 1 / Phase 2UnknownIsfahan University of Medical Sciences502018-09-012018-11-20
StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study
Rosuvastatin - Venous Thromboembolism
Phase 2UnknownOttawa Hospital Research Institute3122016-11-012020-02-27
Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection
Concomitant Tumescent Antibiotic Delivery & IV Delivery, Subcutaneous Tumescent Infiltration, cecefazolin and metronidazole (in a dilute solution of tumescent lidocaine, epinephrin and sodium bicarbonate in 0.9% physiologic saline) - Surgical Site Infections, Venous Thromboembolism
Phase 2 / Phase 3UnknownKlein, Jeffrey A., M.D.4002015-10-012015-07-21
Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients
heparin sodium - Hipolabor, Heparin sodium - APP - Venous Thromboembolism
Phase 2 / Phase 3UnknownAzidus Brasil1402010-05-012010-10-27
Aspirin for the Prevention of Recurrent Venous Thromboembolism
aspirin - Venous Thromboembolism, Deep Venous Thrombosis
Phase 2 / Phase 3UnknownUniversity Of Perugia702004-05-012011-08-23

Narrower conditions

Venous Thromboembolism (6)  ·  Atherosclerosis (1)  ·  Infections (1)  ·  Intracranial Thrombosis (1)  ·  Pulmonary Embolism (1)  ·  Surgical Wound Infection (1)  ·  Thrombosis (1)  ·  Venous Thrombosis (1)  ·  Wounds and Injuries (1)

Broader conditions

Cardiovascular Diseases (7)  ·  Embolism and Thrombosis (7)  ·  Vascular Diseases (7)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Embolism (1)  ·  Intracranial Embolism and Thrombosis (1)  ·  Lung Diseases (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

(+-)-(1'R*,2'S*,6'R*)-(2-hydroxy-4,6-dimethoxyphenyl)(3'-methyl-2'-(3''-methylbut-2''-enyl)-6-phenylcyclohex-3'-enyl)methanone (1)  ·  Aspirin (1)  ·  Dalteparin (1)  ·  Epinephrine (1)  ·  Metronidazole (1)  ·  Parturition (1)  ·  Rivaroxaban (1)  ·  Rosuvastatin Calcium (1)  ·  Sodium Bicarbonate (1)  ·  Warfarin (1)

Sponsors

Alexandre Tran (1)  ·  Azidus Brasil (1)  ·  Isfahan University of Medical Sciences (1)  ·  Klein, Jeffrey A., M.D. (1)  ·  Ottawa Hospital Research Institute (1)  ·  PharmaDiall Ltd. (1)  ·  University Of Perugia (1)

Countries

Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Iran (1)  ·  Italy (1)  ·  Norway (1)  ·  Russia (1)

Top investigators

Alexandre Tran, MD, MSc, FRCSC (1)  ·  Cecilia Becattini, MD (1)  ·  Dmitry A Napalkov, Professor (1)  ·  Giancarlo Agnelli, MD (1)  ·  Marc Carrier, MD, MSc, FRCPC (1)  ·  Marc Rodger, M.D. (1)  ·  Mohammad Saadatnia, Prof (1)  ·  Paolo Prandoni, PhD (1)

Results publications

PMID 22621626, PMID 35344784, PMID 35876829